Skip to content
  • KOSPI 2855.77 +43.72 +1.55%
  • KOSDAQ 764.21 +7.98 +1.06%
  • KOSPI200 382.99 +6.45 +1.72%
  • USD/KRW 1359 14.00 -1.03%
View Market Snapshot

Omlyclo

 Search results

Scope

Date

~

  • Bio & Pharma

    Celltrion gets approval of Omlyclo in Canada

    South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...

    Dec 09, 2024 (Gmt+09:00)

1